I don’t know but this doesn’t sound encouraging at all.
The language suggests a collaboration or a stake sale as Satipharm are not capable of bringing it to market any time soon?
A collaboration would just be placing the research on further life support for an indefinite period.
A stake sale to a more established Pharma may be positive as it would then put a tangible value to the patents and research done. Either way it means revenue from this Avenue is not going to be coming for awhile
I don’t know but this doesn’t sound encouraging at all. The...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HGV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.833M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 291807 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 13115 | 1 |
View Market Depth
| Last trade - 16.12pm 26/07/2024 (20 minute delay) ? |
| HGV (ASX) Chart |
Day chart unavailable